 |
Definition |
 |
Need to breathe |
 |
Lung structure |
 |
Mucus clearing |
 |
Bronchial ‘hyperresponsiveness’ |
 |
Who gets asthma |
 |
International differences |
 |
Recent trends |
 |
Symptoms |
 |
Physical examination |
 |
Lung function tests |
 |
Patterns of peak flow readings |
| |
Response to treatment |
| |
Limitations of peak flow readings |
| |
Chest x-rays |
| |
Blood and ‘allergy’ tests |
| |
Antigens and antibodies |
| |
Skin prick testing |
| |
Difficulties in diagnosis |
| |
Severity of asthma
|
 |
Cells of the immune system |
 |
Risk factors for asthma |
 |
Host factors |
 |
Environmental factors |
 |
House dust mite |
 |
Identifying trigger factors |
 |
Identifying atopy |
 |
Stopping smoking |
 |
House dust mite |
 |
Moulds |
 |
Pollen |
 |
Exercise |
 |
Drug therapy |
 |
Food allergy |
 |
Desensitisation |
 |
Steroids |
 |
Sodium cromoglycate and nedocromil |
 |
Leukotriene receptor antagonists |
 |
Bronchodilators |
 |
Theophylline |
 |
Anticholinergics |
 |
Controllers and relievers |
 |
Antihistamines |
 |
Inhaler devices |
 |
Pressurised metered dose inhalers |
 |
Spacers |
 |
Dry powder inhalers |
 |
Nebulisers |